| Year |
Citation |
Score |
| 2023 |
Pradhan L, Moore D, Ovadia EM, Swedzinski SL, Cossette T, Sikes RA, van Golen K, Kloxin AM. Dynamic bioinspired coculture model for probing ER breast cancer dormancy in the bone marrow niche. Science Advances. 9: eade3186. PMID 36888709 DOI: 10.1126/sciadv.ade3186 |
0.339 |
|
| 2017 |
Lertsuwan K, Peters W, Johnson L, Lertsuwan J, Marwa I, Sikes RA. Purinergic Receptor Expression and Cellular Responses to Purinergic Agonists in Human Prostate Cancer Cells. Anticancer Research. 37: 529-537. PMID 28179298 DOI: 10.21873/Anticanres.11345 |
0.816 |
|
| 2017 |
Lertsuwan K, Choe LH, Marwa IR, Lee K, Sikes RA. Identification of Fibulin-1 as a Human Bone Marrow Stromal (HS-5) Sell-Derived Factor That Induces Human Prostate Cancer Cell Death. The Prostate. PMID 28168724 DOI: 10.1002/Pros.23303 |
0.476 |
|
| 2015 |
Miles FL, Lynch JE, Sikes RA. Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions. Journal of Biological Methods. 2. PMID 26937420 DOI: 10.14440/jbm.2015.73 |
0.675 |
|
| 2015 |
Miles FL, Kurtoglu S, Ahmer C, Soori M, Favate JS, Sikes RA. Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells. The Prostate. 75: 1802-13. PMID 26392321 DOI: 10.1002/Pros.23060 |
0.819 |
|
| 2014 |
Jansson KH, Castillo DG, Morris JW, Boggs ME, Czymmek KJ, Adams EL, Schramm LP, Sikes RA. Identification of beta-2 as a key cell adhesion molecule in PCa cell neurotropic behavior: a novel ex vivo and biophysical approach. Plos One. 9: e98408. PMID 24892658 DOI: 10.1371/Journal.Pone.0098408 |
0.783 |
|
| 2014 |
Miles FL, Sikes RA. Insidious changes in stromal matrix fuel cancer progression. Molecular Cancer Research : McR. 12: 297-312. PMID 24452359 DOI: 10.1158/1541-7786.Mcr-13-0535 |
0.777 |
|
| 2013 |
Dong X, Xu W, Sikes RA, Wu C. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chemistry. 141: 1923-33. PMID 23870911 DOI: 10.1016/J.Foodchem.2013.04.109 |
0.484 |
|
| 2013 |
Lertsuwan J, Sikes R. Abstract P2-09-20: 2’(3’)-O-(4-benzoylbenzoyl)adenosine 5’-triphosphate (BzATP) is a potential drug for triple negative breast cancer: Autophagy and apoptosis inducer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-09-20 |
0.422 |
|
| 2012 |
Dong X, Xu W, Sikes RA, Wu C. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells. Food Chemistry. 135: 1643-52. PMID 22953905 DOI: 10.1016/J.Foodchem.2012.06.023 |
0.493 |
|
| 2012 |
Hillyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines. Clinical & Experimental Metastasis. 29: 971-9. PMID 22610818 DOI: 10.1007/S10585-012-9486-0 |
0.374 |
|
| 2012 |
Miles FL, Tung NS, Aguiar AA, Kurtoglu S, Sikes RA. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling. The Prostate. 72: 1339-50. PMID 22228025 DOI: 10.1002/Pros.22482 |
0.778 |
|
| 2012 |
Jansson KH, Lynch JE, Lepori-Bui N, Czymmek KJ, Duncan RL, Sikes RA. Overexpression of the VSSC-associated CAM, β-2, enhances LNCaP cell metastasis associated behavior. The Prostate. 72: 1080-92. PMID 22127840 DOI: 10.1002/Pros.21512 |
0.798 |
|
| 2011 |
Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, Chung LW, Farach-Carson MC. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. The Prostate. 71: 157-67. PMID 20665531 DOI: 10.1002/Pros.21231 |
0.769 |
|
| 2011 |
Li Y, Sikes RA, Malaeb BS, Yeung F, Law A, Graham SE, Pei M, Kao C, Nelson J, Koeneman KS, Chung LW. Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models. Urologic Oncology. 29: 802-8. PMID 20451417 DOI: 10.1016/J.Urolonc.2009.09.016 |
0.59 |
|
| 2010 |
Degraff DJ, Aguiar AA, Chen Q, Adams LK, Williams BJ, Sikes RA. Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCaP human prostate cancer cells. American Journal of Translational Research. 2: 200-8. PMID 20407609 |
0.804 |
|
| 2010 |
Chen Q, DeGraff DJ, Sikes RA. The developmental expression profile of PAX2 in the murine prostate. The Prostate. 70: 654-65. PMID 20017165 DOI: 10.1002/Pros.21099 |
0.741 |
|
| 2010 |
Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF, Chung LW. Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells. European Urology. 58: 162-71. PMID 19747763 DOI: 10.1016/J.Eururo.2009.08.026 |
0.6 |
|
| 2010 |
Miles FL, Sikes RA. Abstract 3184: TGF-β1 signaling inhibits proliferation but promotes motility with progression to castrate-resistant prostate cancer Cancer Research. 70: 3184-3184. DOI: 10.1158/1538-7445.Am10-3184 |
0.805 |
|
| 2009 |
Degraff DJ, Aguiar AA, Sikes RA. Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions. American Journal of Translational Research. 1: 115-30. PMID 19956425 |
0.798 |
|
| 2009 |
Gomes RR, Buttke P, Paul EM, Sikes RA. Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation. Clinical & Experimental Metastasis. 26: 641-51. PMID 19421879 DOI: 10.1007/S10585-009-9263-X |
0.431 |
|
| 2009 |
Chung SW, Miles FL, Sikes RA, Cooper CR, Farach-Carson MC, Ogunnaike BA. Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophysical Journal. 96: 1733-50. PMID 19254534 DOI: 10.1016/J.Bpj.2008.11.050 |
0.734 |
|
| 2009 |
Pritchard C, Mecham B, Dumpit R, Coleman I, Bhattacharjee M, Chen Q, Sikes RA, Nelson PS. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Research. 69: 1739-47. PMID 19223557 DOI: 10.1158/0008-5472.Can-07-6817 |
0.556 |
|
| 2008 |
Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, ... ... Sikes RA, et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309. PMID 18561328 DOI: 10.1002/Jcb.21785 |
0.464 |
|
| 2007 |
Degraff DJ, Malik M, Chen Q, Miyako K, Rejto L, Aguiar AA, Bancroft DR, Cohen P, Sikes RA. Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model. Journal of Cellular Physiology. 213: 261-8. PMID 17492783 DOI: 10.1002/Jcp.21123 |
0.81 |
|
| 2007 |
Deeble PD, Cox ME, Frierson HF, Sikes RA, Palmer JB, Davidson RJ, Casarez EV, Amorino GP, Parsons SJ. Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells. Cancer Research. 67: 3663-72. PMID 17440078 DOI: 10.1158/0008-5472.Can-06-2616 |
0.595 |
|
| 2006 |
Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA. Voltage-sensitive ion channels and cancer. Cancer Metastasis Reviews. 25: 493-500. PMID 17111226 DOI: 10.1007/S10555-006-9017-Z |
0.306 |
|
| 2006 |
Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, Edlund M. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. Bmc Cancer. 6: 197. PMID 16869958 DOI: 10.1186/1471-2407-6-197 |
0.642 |
|
| 2006 |
Chen Q, Watson JT, Marengo SR, Decker KS, Coleman I, Nelson PS, Sikes RA. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo. Cancer Letters. 244: 274-88. PMID 16500022 DOI: 10.1016/J.Canlet.2005.12.027 |
0.48 |
|
| 2006 |
Thalmann G, Rhee H, Sikes R, Pathak S, Zhau H, Studer U, Chung L. INDUCTION OF PROSTATE CANCER CELL GROWTH, ANDROGENINDEPENDENCE AND BONE METASTASIS IN LNCAP CELLS BY HUMAN PROSTATE FIBROBLASTS OF DIFFERENT ZONAL ORIGIN European Urology Supplements. 5: 790. DOI: 10.1016/S1569-9056(06)61266-9 |
0.552 |
|
| 2006 |
Thalmann G, Rhee H, Sikes R, Pathak S, Zhau H, Studer U, Chung L. HUMAN PROSTATE FIBROBLASTS OF DIFFERENT ZONAL ORIGIN INDUCE LNCAP CELL PROLIFERATION, ANDROGEN INDEPENDENCE AND BONE METASTASIS European Urology Supplements. 5: 126. DOI: 10.1016/S1569-9056(06)60421-1 |
0.466 |
|
| 2006 |
Thalmann GN, Atlanta HR, Sikes R, Pathak S, Zhau HE, Studer UE, Chung LW. 414: Induction of LNCAP Cell Growth, Androgen-Independence and Bone Metastasis by Human Prostate Fibroblasts of Different Zonal Origin Journal of Urology. 175: 135-135. DOI: 10.1016/S0022-5347(18)32670-3 |
0.554 |
|
| 2004 |
Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Research. 64: 8620-9. PMID 15574769 DOI: 10.1158/0008-5472.Can-04-2446 |
0.557 |
|
| 2004 |
Brennen WN, Cooper CR, Capitosti S, Brown ML, Sikes RA. Thalidomide and analogues: current proposed mechanisms and therapeutic usage. Clinical Prostate Cancer. 3: 54-61. PMID 15279692 DOI: 10.3816/Cgc.2004.N.014 |
0.488 |
|
| 2004 |
Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Cellular interactions in the tropism of prostate cancer to bone. International Journal of Cancer. Journal International Du Cancer. 110: 497-503. PMID 15122581 DOI: 10.1002/Ijc.20153 |
0.551 |
|
| 2004 |
Cooper CR, Sikes RA, Nicholson BE, Sun YX, Pienta KJ, Taichman RS. Cancer cells homing to bone: the significance of chemotaxis and cell adhesion. Cancer Treatment and Research. 118: 291-309. PMID 15043197 DOI: 10.1007/978-1-4419-9129-4_12 |
0.481 |
|
| 2004 |
Stewart DA, Cooper CR, Sikes RA. Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reproductive Biology and Endocrinology : Rb&E. 2: 2. PMID 14711377 DOI: 10.1186/1477-7827-2-2 |
0.574 |
|
| 2003 |
Sikes RA, Walls AM, Brennen WN, Anderson JD, Choudhury-Mukherjee I, Schenck HA, Brown ML. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers. Clinical Prostate Cancer. 2: 181-7. PMID 15040863 DOI: 10.3816/Cgc.2003.N.028 |
0.591 |
|
| 2003 |
Abbott DE, Pritchard C, Clegg NJ, Ferguson C, Dumpit R, Sikes RA, Nelson PS. Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate. Genome Biology. 4: R79. PMID 14659016 DOI: 10.1186/Gb-2003-4-12-R79 |
0.489 |
|
| 2003 |
Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling M, Höll GM, Patel MK, Sikes RA, Brown ML. Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Molecular Cancer Therapeutics. 2: 1149-54. PMID 14617788 |
0.398 |
|
| 2003 |
Tennant MK, Vessella RL, Sprenger CC, Sikes RA, Hwa V, Baker LD, Plymate SR. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts. The Prostate. 56: 115-22. PMID 12746836 DOI: 10.1002/Pros.10223 |
0.548 |
|
| 2003 |
Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Research. 63: 1981-9. PMID 12702592 |
0.446 |
|
| 2003 |
Guo N, Ye JJ, Liang SJ, Mineo R, Li SL, Giannini S, Plymate SR, Sikes RA, Fujita-Yamaguchi Y. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 13: 44-53. PMID 12550081 DOI: 10.1016/S1096-6374(02)00121-1 |
0.607 |
|
| 2003 |
Thalmann G, Sikes R, Bisoffi M, Nelson P, Wetterwald A, Studer U, Cecchini M. Gene expression profiles in the LNCAP model of human prostate cancer progression: Upregulation of osteomimetic peptides European Urology Supplements. 2: 58. DOI: 10.1016/S1569-9056(03)80230-0 |
0.407 |
|
| 2000 |
Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. The Prostate. 44: 91-103 Jul 1;44(2). PMID 10881018 DOI: 10.1002/1097-0045(20000701)44:2<91::Aid-Pros1>3.0.Co;2-L |
0.624 |
|
| 2000 |
Degeorges A, Wang F, Frierson HF, Seth A, Sikes RA. Distribution of IGFBP-rP1 in normal human tissues Journal of Histochemistry and Cytochemistry. 48: 747-754. PMID 10820148 DOI: 10.1177/002215540004800603 |
0.444 |
|
| 1999 |
Hyytinen ER, Frierson HF, Sipe TW, Li CL, Degeorges A, Sikes RA, Chung LWK, Dong JT. Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer Prostate. 41: 190-195. PMID 10517877 DOI: 10.1002/(Sici)1097-0045(19991101)41:3<190::Aid-Pros6>3.0.Co;2-2 |
0.507 |
|
| 1999 |
Theodorescu D, Frierson HF, Sikes RA. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy Journal of Urology. 161: 1442-1448. PMID 10210369 DOI: 10.1016/S0022-5347(05)68919-7 |
0.517 |
|
| 1999 |
Koeneman KS, Yeung F, Sikes RA, Chung LWK, Nelson JB. TRANSCRIPTIONAL DOWNREGULATION OF PSA, AND ENHANCED GROWTH OF PROSTATE CANCER (CaP) CELLS BY CO-CULTURE WITH OSTEOBLASTIC CELLS The Journal of Urology. 99. DOI: 10.1097/00005392-199904010-00397 |
0.61 |
|
| 1999 |
Zhau HE, Li C, Yang H, Dong J, Frierson H, Sikes RA, Wang Y, Sipe TW, Chung LWK. Genotypic Comparison Of Prostate Cancers Among U.S. Whites, U.S. Blacks, And Mainland Chinese Men The Journal of Urology. 70. DOI: 10.1097/00005392-199904010-00284 |
0.447 |
|
| 1998 |
Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. International Journal of Cancer. Journal International Du Cancer. 77: 887-94. PMID 9714059 DOI: 10.1002/(Sici)1097-0215(19980911)77:6<887::Aid-Ijc15>3.0.Co;2-Z |
0.558 |
|
| 1998 |
Chen ME, Lin SH, Chung LW, Sikes RA. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. The Journal of Biological Chemistry. 273: 17618-25. PMID 9651357 DOI: 10.1074/Jbc.273.28.17618 |
0.571 |
|
| 1998 |
Vafa A, Zhang Y, Sikes RA, Marengo SR. Overexpression of p185erbB2/neu in the NbE prostatic epithelial cell line increases cellular spreading and the expression of integrin alpha6beta1. International Journal of Oncology. 13: 1191-1197. DOI: 10.3892/Ijo.13.6.1191 |
0.546 |
|
| 1997 |
Cleutjens KBJM, Van Der Korput HAGM, Ehren-van Eekelen CC, Sikes RA, Fasciana C, Chung LW, Trapman J. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans Molecular Endocrinology. 11: 1256-1265. PMID 9259317 DOI: 10.1210/Mend.11.9.9974 |
0.516 |
|
| 1997 |
Marengo SR, Sikes RA, Anezinis P, Chang SM, Chung LW. Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE). Molecular Carcinogenesis. 19: 165-75. PMID 9254883 DOI: 10.1002/(Sici)1098-2744(199707)19:3<165::Aid-Mc4>3.0.Co;2-D |
0.533 |
|
| 1996 |
Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. Journal of the National Cancer Institute. 88: 794-801. PMID 8637045 DOI: 10.1093/Jnci/88.12.794 |
0.577 |
|
| 1996 |
Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW. Transfected neu oncogene induces human prostate cancer metastasis. The Prostate. 28: 73-83. PMID 8604395 DOI: 10.1002/(Sici)1097-0045(199602)28:2<73::Aid-Pros1>3.0.Co;2-O |
0.56 |
|
| 1994 |
He XY, Sikes RA, Thomsen S, Chung LW, Jacques SL. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochemistry and Photobiology. 59: 468-73. PMID 8022890 DOI: 10.1111/J.1751-1097.1994.Tb05066.X |
0.372 |
|
| 1993 |
He XY, Sikes RA, Thomsen SLMD, Chung LW, Jacques SL. Photodynamic therapy-induced programmed cell death in carcinoma cell lines Proceedings of Spie. 1881: 285-295. DOI: 10.1117/12.146321 |
0.375 |
|
| 1992 |
Chung LW, Li W, Gleave ME, Hsieh JT, Wu HC, Sikes RA, Zhau HE, Bandyk MG, Logothetis CJ, Rubin JS. Human prostate cancer model: roles of growth factors and extracellular matrices Journal of Cellular Biochemistry. Supplement. 16: 99-105. PMID 1289680 DOI: 10.1002/Jcb.240501222 |
0.591 |
|
| 1990 |
Sikes RA, Thomsen S, Petrow V, Neubauer BL, Chung LW. Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration. Biology of Reproduction. 43: 353-62. PMID 1696141 DOI: 10.1095/Biolreprod43.2.353 |
0.498 |
|
| Show low-probability matches. |